Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Altered macrophage differentiation and immune dysfunction in tumor development
Antonio Sica, Vincenzo Bronte
Antonio Sica, Vincenzo Bronte
Published May 1, 2007
Citation Information: J Clin Invest. 2007;117(5):1155-1166. https://doi.org/10.1172/JCI31422.
View: Text | PDF
Review Series Article has an altmetric score of 6

Altered macrophage differentiation and immune dysfunction in tumor development

  • Text
  • PDF
Abstract

Tumors require a constant influx of myelomonocytic cells to support the angiogenesis and stroma remodeling needed for their growth. This is mediated by tumor-derived factors, which cause sustained myelopoiesis and the accumulation and functional differentiation of myelomonocytic cells, most of which are macrophages, at the tumor site. An important side effect of the accumulation and functional differentiation of these cells is that they can induce lymphocyte dysfunction. A complete understanding of the complex interplay between neoplastic and myelomonocytic cells might offer novel targets for therapeutic intervention aimed at depriving tumor cells of important growth support and enhancing the antitumor immune response.

Authors

Antonio Sica, Vincenzo Bronte

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 Total
Citations: 11 25 21 41 35 41 32 32 35 29 33 44 36 47 33 48 27 22 3 595
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2010 (48)

Title and authors Publication Year
IL-10/TGF-beta-modified macrophages induce regulatory T cells and protect against adriamycin nephrosis
Q Cao, Y Wang, D Zheng, Y Sun, Y Wang, VW Lee, G Zheng, TK Tan, J Ince, SI Alexander, DC Harris
Journal of the American Society of Nephrology : JASN 2010
TLR4/MyD88-induced CD11b+Gr-1intF4/80+ non-migratory myeloid cells suppress Th2 effector function in the lung
M Arora, SL Poe, TB Oriss, N Krishnamoorthy, M Yarlagadda, SE Wenzel, TR Billiar, A Ray, P Ray
Mucosal Immunology 2010
Anti-HER2 vaccines: new prospects for breast cancer therapy
MZ Ladjemi, W Jacot, T Chardès, A Pèlegrin, I Navarro-Teulon
Cancer Immunology, Immunotherapy 2010
Directing dendritic cell immunotherapy towards successful cancer treatment
RL Sabado, N Bhardwaj
Immunotherapy 2010
Transforming growth factor beta (TGF-β) and inflammation in cancer
B Bierie, HL Moses
Cytokine & Growth Factor Reviews 2010
Pivotal Advance: Tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE 2 catabolism in myeloid cells
E Eruslanov, I Daurkin, J Ortiz, J Vieweg, S Kusmartsev
Journal of leukocyte biology 2010
Blockade of programmed death-1 pathway rescues the effector function of tumor-infiltrating T cells and enhances the antitumor efficacy of lentivector immunization
Q Zhou, H Xiao, Y Liu, Y Peng, Y Hong, H Yagita, P Chandler, DH Munn, A Mellor, N Fu, Y He
Journal of immunology (Baltimore, Md. : 1950) 2010
Tumor masses support naive T cell infiltration, activation, and differentiation into effectors
ED Thompson, HL Enriquez, YX Fu, VH Engelhard
Journal of Experimental Medicine 2010
Oxidative stress, inflammation, and cancer: How are they linked?
S Reuter, SC Gupta, MM Chaturvedi, BB Aggarwal
Free radical biology & medicine 2010
Elusive identities and overlapping phenotypes of proangiogenic myeloid cells in tumors
SB Coffelt, CE Lewis, L Naldini, JM Brown, N Ferrara, MD Palma
The American Journal of Pathology 2010
The Tumor Microenvironment in Colorectal Carcinogenesis
VG Peddareddigari, D Wang, RN Dubois
Cancer Microenvironment 2010
DNA vaccines: developing new strategies against cancer
D Fioretti, S Iurescia, VM Fazio, M Rinaldi
Journal of biomedicine & biotechnology 2010
Immunologic mechanisms in RCC and allogeneic renal transplant rejection
J Bedke, A Stenzl
Nature Reviews Urology 2010
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
SK Biswas, A Mantovani
Nature Immunology 2010
Tumor progression stage and anatomical site regulate tumor-associated macrophage and bone marrow-derived monocyte polarization
EF Redente, LD Dwyer-Nield, DT Merrick, K Raina, R Agarwal, W Pao, PL Rice, KR Shroyer, AM Malkinson
The American Journal of Pathology 2010
Monocytes and macrophages regulate immunity through dynamic networks of survival and cell death
A Parihar, TD Eubank, AI Doseff
Journal of Innate Immunity 2010
Chronic alcohol consumption enhances myeloid-derived suppressor cells in B16BL6 melanoma-bearing mice
H Zhang, GG Meadows
Cancer Immunology, Immunotherapy 2010
Subsets, expansion and activation of myeloid-derived suppressor cells
E Ribechini, V Greifenberg, S Sandwick, MB Lutz
Medical Microbiology and Immunology 2010
The biology of myeloid-derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity
JI Youn, DI Gabrilovich
European Journal of Immunology 2010
Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function
T Condamine, DI Gabrilovich
Trends in Immunology 2010
A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumor bearers
KN Kodumudi, K Woan, DL Gilvary, E Sahakian, S Wei, JY Djeu
Clinical cancer research 2010
Tim-3/Galectin-9 Pathway: Regulation of Th1 Immunity through Promotion of CD11b + Ly-6G + Myeloid Cells
V Dardalhon, AC Anderson, J Karman, L Apetoh, R Chandwaskar, DH Lee, M Cornejo, N Nishi, A Yamauchi, FJ Quintana, RA Sobel, M Hirashima, VK Kuchroo
Journal of immunology (Baltimore, Md. : 1950) 2010
Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humans
LS Metelitsa
Clinical Immunology 2010
xCT deficiency accelerates chemically induced tumorigenesis
A Nabeyama, A Kurita, K Asano, Y Miyake, T Yasuda, I Miura, G Nishitai, S Arakawa, S Shimizu, S Wakana, H Yoshida, M Tanaka
Proceedings of the National Academy of Sciences 2010
Crosstalk between decidual NK and CD14+ myelomonocytic cells results in induction of Tregs and immunosuppression
P Vacca, C Cantoni, M Vitale, C Prato, F Canegallo, D Fenoglio, N Ragni, L Moretta, MC Mingari
Proceedings of the National Academy of Sciences 2010
Up for Mischief? IL-17/Th17 in the tumour microenvironment
E Maniati, R Soper, T Hagemann
Oncogene 2010
Ovarian cancer immunotherapy: opportunities, progresses and challenges
B Liu, J Nash, C Runowicz, H Swede, R Stevens, Z Li
Journal of Hematology & Oncology 2010
Overview of a HLA-Ig based "Lego-like system" for T cell monitoring, modulation and expansion
M Oelke, JP Schneck
Immunologic Research 2010
The tumor microenvironment of colorectal cancer: stromal TLR-4 expression as a potential prognostic marker
R Cammarota, V Bertolini, G Pennesi, EO Bucci, O Gottardi, C Garlanda, L Laghi, MC Barberis, F Sessa, DM Noonan, A Albini
Journal of Translational Medicine 2010
HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment
CA Corzo, T Condamine, L Lu, MJ Cotter, JI Youn, P Cheng, HI Cho, E Celis, DG Quiceno, T Padhya, TV McCaffrey, JC McCaffrey, DI Gabrilovich
Journal of Experimental Medicine 2010
Interleukin-10 production by tumor infiltrating macrophages plays a role in Human Papillomavirus 16 tumor growth
A Bolpetti, JS Silva, LL Villa, AP Lepique
BMC Immunology 2010
The transcription factor RBP-J-mediated signaling is essential for dendritic cells to evoke efficient anti-tumor immune responses in mice
F Feng, YC Wang, XB Hu, XW Liu, G Ji, YR Chen, L Wang, F He, GR Dou, L Liang, HW Zhang, H Han
Molecular Cancer 2010
The role of NF-kappaB and H3K27me3 demethylase, Jmjd3, on the anthrax lethal toxin tolerance of RAW 264.7 cells
ND Das, KH Jung, YG Chai
PloS one 2010
Critical roles of lysosomal acid lipase in myelopoiesis
P Qu, WC Shelley, MC Yoder, L Wu, H Du, C Yan
The American Journal of Pathology 2010
Vaccine against MUC1 antigen expressed in inflammatory bowel disease and cancer lessens colonic inflammation and prevents progression to colitis-associated colon cancer
PL Beatty, S Narayanan, J Gariépy, S Ranganathan, OJ Finn
Cancer prevention research (Philadelphia, Pa.) 2010
iNKT cells control mouse spontaneous carcinoma independently of tumor-specific cytotoxic T cells
M Bellone, M Ceccon, M Grioni, E Jachetti, A Calcinotto, A Napolitano, M Freschi, G Casorati, P Dellabona
PloS one 2010
Tumor growth and angiogenesis are dependent on the presence of immature dendritic cells
O Fainaru, N Almog, CW Yung, K Nakai, M Montoya-Zavala, A Abdollahi, R D'Amato, DE Ingber
The FASEB Journal 2010
Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD
E Tili, JJ Michaille, B Adair, H Alder, E Limagne, C Taccioli, M Ferracin, D Delmas, N Latruffe, CM Croce
Carcinogenesis 2010
Tumor-associated macrophages are predominant carriers of cyclodextrin-based nanoparticles into gliomas
D Alizadeh, L Zhang, J Hwang, T Schluep, B Badie
Nanomedicine: Nanotechnology, Biology and Medicine 2010
Fes Tyrosine Kinase Expression in the Tumor Niche Correlates with Enhanced Tumor Growth, Angiogenesis, Circulating Tumor Cells, Metastasis, and Infiltrating Macrophages
S Zhang, V Chitu, ER Stanley, BE Elliott, PA Greer
Cancer research 2010
miR-200 Inhibits Lung Adenocarcinoma Cell Invasion and Metastasis by Targeting Flt1/VEGFR1
JD Roybal, Y Zang, YH Ahn, Y Yang, DL Gibbons, BN Baird, C Alvarez, N Thilaganathan, DD Liu, P Saintigny, JV Heymach, CJ Creighton, JM Kurie
Molecular cancer research : MCR 2010
Environmental control of invasiveness and metastatic dissemination of tumor cells: the role of tumor cell-host cell interactions
L Calorini, F Bianchini
Cell Communication and Signaling 2010
Anti-inflammatory Triterpenoid Blocks Immune Suppressive Function of MDSCs and Improves Immune Response in Cancer
S Nagaraj, JI Youn, H Weber, C Iclozan, L Lu, MJ Cotter, C Meyer, CR Becerra, M Fishman, S Antonia, MB Sporn, KT Liby, B Rawal, JH Lee, DI Gabrilovich
Clinical cancer research 2010
Migration or evasion.
Melief C
Nature Medicine 2010
Involvement of M2‐polarized macrophages in the ascites from advanced epithelial ovarian carcinoma in tumor progression via Stat3 activation
Takaishi K, Komohara Y, Tashiro H, Ohtake H, Nakagawa T, Katabuchi H, Takeya M
Cancer Science 2010
Organ microenvironment plays significant roles through Fas ligand in vaccine‐induced CD4+ T cell dependent suppression of tumor growth at the orthotopic site
Sugiura D, Denda\u2010Nagai K, Takeda K, Irimura T
Cancer Science 2010
Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma
Hasita H, Komohara Y, Okabe H, Masuda T, Ohnishi K, Lei XF, Beppu T, Baba H, Takeya M
Cancer Science 2010
Corosolic acid inhibits glioblastoma cell proliferation by suppressing the activation of signal transducer and activator of transcription‐3 and nuclear factor‐kappa B in tumor cells and tumor‐associated macrophages
Fujiwara Y, Komohara Y, Ikeda T, Takeya M
Cancer Science 2010

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 8 patents
670 readers on Mendeley
1 readers on CiteULike
See more details